W.K. Wells and Alfred G. Collins III evaluate patent eligibility of computer-related innovations in the U.S., due to their ‘abstract’ nature, following several cases that have questioned the reliability of DNA recognition inventions.

Chengzhe CUI, Partner at Beijing Sanyou Intellectual Property Agency Ltd., evaluates the process for remuneration on service invention by reviewing the 3M multijurisdictional case.

John W. Cox, Ph.D., Partner at Barnes & Thornburg LLP, provides an overview of the role of patents from the beginning of an endeavor and their relation to corporate success, and provides a hypothetical life cycle with relevant milestones along the way.

John XIA, Partner & Patent Attorney at Corner Stone and Partners, gives a brief overview of China’s Administrative Adjudication Measures for Major Patent Infringement Disputes.

Jaime D. Choi, Ph.D., Partner at Snell & Wilmer, expounds on the importance of provisional applications, listing the benefits that can be reaped from these inexpensive filings.

The latest IP Trend Monitor study, published by Dennemeyer in partnership with CTC Legal Media, focuses on how IP management is changing. Building on previous years’ reports, it provides a snapshot of what IP experts think about the recovery from the pandemic, how to succeed in today’s world and where changes are needed.

Featuring: Zixuan Wang of Kommit

Featuring: Maria Zamkova of Fenix Legal

10 of the best law firms from each of the top European jurisdictions, including Czech Republic, Germany, Poland and the UK.

Dr. Tatiana Vakhnina & Dr. Alexey Vakhnin of Vakhnina & Partners discuss the increase of official fees; new countries to join the EAPO protocol on Eurasian Designs; implementation of fully electronic and paperless proceedings following the recent EAPO meeting.

David McCombs, Eugene Goryunov, Dina Blikshteyn & Nicolette Nunez of Haynes & Boone evaluate the progression of AI in the finance space and express key reasons to patent these new technologies.

Daniel Tjoernelund and Sharon Meyer of Azami Global evaluate the filing process for life sciences patents with advice for protecting inventions on a global scale.

Efrain Olmedo and José Pablo Pérez Zea of Santamarina + Steta examine the rapid development of AI and its application and use in the medical field, evaluating the patentability of these inventions under Mexican law.

KOREJZOVA LEGAL analyze how the Biotech Directive harmonizes the specification of inventions to be, or not be, patentable due to ethical grounds in the EU.

Fabian Koenigbauer, patent attorney at Ice Miller, reviews the America Invents Act trial process and offers strategic advice for strength and success.

Tang Xiaofeng, Patent Attorney at Beijing Geach Intellectual Property Law Office, examines the case of the invalidated Ticagrelor crystalline form patent CN200610002509.5 of AstraZeneca, explaining why he believes the patent should in fact be maintained.

Mônica Gurvitz and Julia Fernandes, Partners at Montaury Pimenta, Machado & Vieira de Mello, evaluate the implementation of the ADI 5,529 one year on.

Dr. Rebecca McFadyen and Dr. Tara Nealey of Polsinelli review the original implementation of the Bayh-Dole Act and why there are now petitions to use either march-in or government use rights to remedy unjustifiable drug pricing.

Janett Lumbreras, Senior Associate at Uhthoff, Gomez Vega & Uhthoff S.C, explains the functions and benefits of CRISPR technology and how it can be protected in Mexico.

Roger Kuan, Jason Novak and Eric Ong examine the threat that the TRIPS Agreement poses to life sciences companies when it comes to protecting their COVID-19 related inventions.

Ricardo Costa Macedo, Head of the Life Sciences and Intellectual Property groups at Caiado Guerreiro, clarifies the available intellectual property protection in the healthcare industry including trademarks, patents, domain names, and trade secrets.